CMA1 and Hepatic fibrosis: The mast cell stabilizer tranilast could inhibit the activation of mast cells, blocking the release of chymase and thereby preventing the development of hepatic fibrosis in a rat diabetes and HFC diet-induced NASH model (Uno et al., 2008).